PharmEasy-parent API Holdings has agreed to a rights issue to raise ₹2,000-3,000 crore, CNBC-TV18 reported. API Holdings has also approved Manipal Group's proposal, which offered to invest up to ₹1,300 crore, to invest the remaining amount if all investors don't end up participating in the rights issue. Few PharmEasy investors reportedly had reservations on sale of shares to Manipal Group.